首页> 外国专利> As-2 PROTEIN DERIVED FROM ANOPHELES STEPHENSI HAVING BRADYKININ PRODUCTION INHIBITING ACTIVITY AND BLOOD CLOTTING INHIBITION ACTIVITY

As-2 PROTEIN DERIVED FROM ANOPHELES STEPHENSI HAVING BRADYKININ PRODUCTION INHIBITING ACTIVITY AND BLOOD CLOTTING INHIBITION ACTIVITY

机译:得自嗜臭按蚊的AS-2蛋白具有缓激肽的产生抑制活性和血凝抑制活性

摘要

PROBLEM TO BE SOLVED: To provide a new protein having blood clotting inhibition activity and antiinflammatory activity.;SOLUTION: The present invention provides an As-2 protein which is a new protein derived from Anopheles stephensi and provide an As-2 gene encoding the protein. The As-2 protein has bradykinin-production inhibiting activity and, accordingly, pharmaceuticals containing the As-2 protein as an active component are useful as an antiinflammatory agent and analgesic agent. Since the protein has a blood clotting inhibition activity, pharmaceuticals containing the As-2 protein as an active component are useful as a blood clotting inhibition agent for the treatment and prevention of myocardial infarction, pulmonary infarction and cerebral infarction. The As-2 protein is highly expectable also in the field for the development of pharmaceuticals as a leading compound of an antiinflammatory agent, an analgesic agent and a blood clotting inhibitor.;COPYRIGHT: (C)2003,JPO
机译:解决的问题:提供一种具有凝血抑制活性和抗炎活性的新蛋白。解决方案:本发明提供一种As-2蛋白,其是来源于按蚊按蚊的新蛋白并提供编码该蛋白的As-2基因。 As-2蛋白具有缓激肽产生抑制活性,因此,含有As-2蛋白作为活性成分的药物可用作抗炎剂和止痛剂。由于该蛋白质具有抑制血液凝集的活性,因此含有As-2蛋白质作为有效成分的药物可用作治疗和预防心肌梗塞,肺梗塞和脑梗塞的血液凝结剂。作为抗炎剂,止痛剂和凝血抑制剂的主要化合物,As-2蛋白在药物开发领域也非常值得期待。; COPYRIGHT:(C)2003,JPO

著录项

  • 公开/公告号JP2003116571A

    专利类型

  • 公开/公告日2003-04-22

    原文格式PDF

  • 申请/专利权人 MIE UNIV;

    申请/专利号JP20010317257

  • 发明设计人 CHINZEI YASUO;YUDA MASAO;IZAWA HARUHIKO;

    申请日2001-10-15

  • 分类号C12N15/09;A61K38/55;A61P29/00;A61P43/00;C07K14/435;

  • 国家 JP

  • 入库时间 2022-08-22 00:16:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号